642 related articles for article (PubMed ID: 7907956)
1. Selective increase of activation antigens HLA-DR and CD38 on CD4+ CD45RO+ T lymphocytes during HIV-1 infection.
Kestens L; Vanham G; Vereecken C; Vandenbruaene M; Vercauteren G; Colebunders RL; Gigase PL
Clin Exp Immunol; 1994 Mar; 95(3):436-41. PubMed ID: 7907956
[TBL] [Abstract][Full Text] [Related]
2. Expression of activation antigens, HLA-DR and CD38, on CD8 lymphocytes during HIV-1 infection.
Kestens L; Vanham G; Gigase P; Young G; Hannet I; Vanlangendonck F; Hulstaert F; Bach BA
AIDS; 1992 Aug; 6(8):793-7. PubMed ID: 1418775
[TBL] [Abstract][Full Text] [Related]
3. Cell cycling in HIV infection: analysis of in vivo activated lymphocytes.
Mahalingam M; Pozniak A; McManus TJ; Vergani D; Peakman M
Clin Exp Immunol; 1995 Dec; 102(3):481-6. PubMed ID: 8536361
[TBL] [Abstract][Full Text] [Related]
4. Three-color cytofluorometric analysis of CD8 cell subsets in HIV-1 infection.
Prince HE; Jensen ER
J Acquir Immune Defic Syndr (1988); 1991; 4(12):1227-32. PubMed ID: 1719188
[TBL] [Abstract][Full Text] [Related]
5. Quantitative alterations of the functionally distinct subsets of CD4 and CD8 T lymphocytes in asymptomatic HIV infection: changes in the expression of CD45RO, CD45RA, CD11b, CD38, HLA-DR, and CD25 antigens.
Benito JM; Zabay JM; Gil J; Bermejo M; Escudero A; Sánchez E; Fernández-Cruz E
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Feb; 14(2):128-35. PubMed ID: 9052721
[TBL] [Abstract][Full Text] [Related]
6. During HIV infection, CD4+ CD38+ T-cells are the predominant circulating CD4+ subset whose HLA-DR positivity increases with disease progression and whose V beta repertoire is similar to that of CD4+ CD38- T-cells.
Ramzaoui S; Jouen-Beades F; Gilbert D; Borsa-Lebas F; Michel Y; Humbert G; Tron F
Clin Immunol Immunopathol; 1995 Oct; 77(1):33-41. PubMed ID: 7554481
[TBL] [Abstract][Full Text] [Related]
7. Different meaning of CD38 molecule expression on CD4+ and CD8+ cells of children perinatally infected with human immunodeficiency virus type 1 infection surviving longer than five years.
de Martino M; Rossi ME; Azzari C; Gelli MG; Galli L; Vierucci A
Pediatr Res; 1998 Jun; 43(6):752-8. PubMed ID: 9621984
[TBL] [Abstract][Full Text] [Related]
8. Elevated levels of CD38+ CD8+ T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study.
Giorgi JV; Liu Z; Hultin LE; Cumberland WG; Hennessey K; Detels R
J Acquir Immune Defic Syndr (1988); 1993 Aug; 6(8):904-12. PubMed ID: 7686224
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic analysis of CD8+ T lymphocytes in a cohort of HIV type 1-infected patients treated with saquinavir, ritonavir, and two nucleoside analogs for 1 year, and association with plasma HIV type 1 RNA.
Kaufmann GR; Zaunders JJ; Cunningham P; Cooper DA
AIDS Res Hum Retroviruses; 1999 Jul; 15(11):963-72. PubMed ID: 10445808
[TBL] [Abstract][Full Text] [Related]
10. Decreased expression of the memory marker CD26 on both CD4+ and CD8+ T lymphocytes of HIV-infected subjects.
Vanham G; Kestens L; De Meester I; Vingerhoets J; Penne G; Vanhoof G; Scharpé S; Heyligen H; Bosmans E; Ceuppens JL
J Acquir Immune Defic Syndr (1988); 1993 Jul; 6(7):749-57. PubMed ID: 8099610
[TBL] [Abstract][Full Text] [Related]
11. Increased level of activated gamma delta lymphocytes correlates with disease severity in HIV infection.
Norazmi MN; Arifin H; Jamaruddin MA
Immunol Cell Biol; 1995 Jun; 73(3):245-8. PubMed ID: 7590898
[TBL] [Abstract][Full Text] [Related]
12. Highly active antiretroviral therapy during early HIV infection reverses T-cell activation and maturation abnormalities. Swiss HIV Cohort Study.
Bisset LR; Cone RW; Huber W; Battegay M; Vernazza PL; Weber R; Grob PJ; Opravil M
AIDS; 1998 Nov; 12(16):2115-23. PubMed ID: 9833852
[TBL] [Abstract][Full Text] [Related]
13. CD8+CD38+ and CD8+DR+ peripheral blood lymphoid subsets of HIV-infected intravenous drug abusers correlate with CD4+ cell counts and proliferation to mitogens.
Echaniz P; Arrizabalaga J; Iribarren JA; Cuadrado E
Cell Immunol; 1993 Aug; 150(1):72-80. PubMed ID: 7688270
[TBL] [Abstract][Full Text] [Related]
14. Activation and differentiation antigens on T cells of healthy, at-risk, and HIV-infected children.
Plaeger-Marshall S; Hultin P; Bertolli J; O'Rourke S; Kobayashi R; Kobayashi AL; Giorgi JV; Bryson Y; Stiehm ER
J Acquir Immune Defic Syndr (1988); 1993 Sep; 6(9):984-93. PubMed ID: 7688045
[TBL] [Abstract][Full Text] [Related]
15. Increased numbers of primed activated CD8+CD38+CD45RO+ T cells predict the decline of CD4+ T cells in HIV-1-infected patients.
Bofill M; Mocroft A; Lipman M; Medina E; Borthwick NJ; Sabin CA; Timms A; Winter M; Baptista L; Johnson MA; Lee CA; Phillips AN; Janossy G
AIDS; 1996 Jul; 10(8):827-34. PubMed ID: 8828739
[TBL] [Abstract][Full Text] [Related]
16. Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression.
Liu Z; Cumberland WG; Hultin LE; Prince HE; Detels R; Giorgi JV
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Oct; 16(2):83-92. PubMed ID: 9358102
[TBL] [Abstract][Full Text] [Related]
17. HIV-1-specific cytolytic T-lymphocyte activity correlates with lower viral load, higher CD4 count, and CD8+CD38-DR- phenotype: comparison of statistical methods for measurement.
Lubaki NM; Shepherd ME; Brookmeyer RS; Hon H; Quinn TC; Kashamuka M; Johnson M; Gottle R; Devers J; Lederman HM; Bollinger RC
J Acquir Immune Defic Syndr; 1999 Sep; 22(1):19-30. PubMed ID: 10534143
[TBL] [Abstract][Full Text] [Related]
18. Circulating HIV-specific CD8+ cytotoxic T cells express CD38 and HLA-DR antigens.
Ho HN; Hultin LE; Mitsuyasu RT; Matud JL; Hausner MA; Bockstoce D; Chou CC; O'Rourke S; Taylor JM; Giorgi JV
J Immunol; 1993 Apr; 150(7):3070-9. PubMed ID: 8454874
[TBL] [Abstract][Full Text] [Related]
19. Indicators of T-cell activation: correlation between quantitative CD38 expression and soluble CD8 levels in asymptomatic HIV+ individuals and healthy controls.
Lenkei R; Bratt G; Holmberg V; Muirhead K; Sandström E
Cytometry; 1998 Oct; 33(2):115-22. PubMed ID: 9773871
[TBL] [Abstract][Full Text] [Related]
20. Dominant enrichment of phenotypically activated CD38(+) HLA-DR(+) CD8(+) T cells, rather than CD38(+) HLA-DR(+) CD4(+) T cells, in HIV/HCV coinfected patients on antiretroviral therapy.
d'Ettorre G; Ceccarelli G; Serafino S; Giustini N; Cavallari EN; Bianchi L; Pavone P; Bellelli V; Turriziani O; Antonelli G; Stroffolini T; Vullo V
J Med Virol; 2016 Aug; 88(8):1347-56. PubMed ID: 26765625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
